Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice

BMC Immunology

Volumn 13, Issue , 2012, Pages

  Xia, Chang Qing ^a,b   Chernatynskaya, Anna V ^b   Wasserfall, Clive H ^b   Wan, Suigui ^a   Looney, Benjamin M ^b   Eisenbeis, Scott ^c   Williams, John ^c   Clare Salzler, Michael J ^b   Atkinson, Mark A ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c GENZYME CORPORATION   (United States)

Author keywords

Anti thymocyte globulin; Autoimmune diabetes; Na ve and memory T cells; Nonobese diabetic mouse; Regulatory T cells; T helper cell

Indexed keywords

GLYCOPROTEIN P 15095; INTERLEUKIN 10; THYMOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PHENOTYPE; REGULATORY T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; ANTILYMPHOCYTE SERUM; AUTOANTIGENS; CELL PROLIFERATION; CROSS-PRIMING; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; L-SELECTIN; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; LYMPHOID TISSUE; MICE; MICE, INBRED NOD; RECEPTORS, ANTIGEN, T-CELL; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 84870935338     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-13-70     Document Type: Article

References (32)

1. Bacigalupo A. Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects. Bone Marrow Transplant 2005, 35(3):225-231. 10.1038/sj.bmt.1704758, 15558041.
2. Hardinger KL. Rabbit antithymocyte globulin induction therapy in adult renal transplantation. Pharmacotherapy 2006, 26(12):1771-1783. 10.1592/phco.26.12.1771, 17125438.
3. Shapiro R, Young JB, Milford EL, Trotter JF, Bustami RT, Leichtman AB. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant 2005, 5(4 Pt 2):874-886.
4. Chung DT, Korn T, Richard J, Ruzek M, Kohm AP, Miller S, Nahill S, Oukka M. Anti-thymocyte globulin (ATG) prevents autoimmune encephalomyelitis by expanding myelin antigen-specific Foxp3+ regulatory T cells. Int Immunol 2007, 19(8):1003-1010. 10.1093/intimm/dxm078, 17698561.
5. Musso M, Porretto F, Crescimanno A, Bondi F, Polizzi V, Scalone R. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Am J Hematol 2001, 66(2):75-79. 10.1002/1096-8652(200102)66:2<75::AID-AJH1020>3.0.CO;2-V, 11421302.
6. Saudek F, Havrdova T, Boucek P, Karasova L, Novota P, Skibova J. Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset. Rev Diabet Stud 2004, 1(2):80-88. 10.1900/RDS.2004.1.80, 1783538, 17491669.
7. van de Linde P, Tysma OM, Medema JP, Hale G, Waldmann H, Roelen DL, Roep BO. Mechanisms of antibody immunotherapy on clonal islet reactive T cells. Hum Immunol 2006, 67(4-5):264-273.
8. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, Leverger G, Leporrier M, Reiffers J, Janvier M, et al. A multicenter randomized study comparing cyclosporin-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. The cooperative group on the treatment of aplastic anemia. J Autoimmun 1992, 5(Suppl A):271-275.
9. Mohty M. Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia 2007, 21(7):1387-1394. 10.1038/sj.leu.2404683, 17410187.
10. Huang Y, Parker M, Xia C, Peng R, Wasserfall C, Clarke T, Wu L, Chowdhry T, Campbell-Thompson M, Williams J, et al. Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses. J Immunol 2009, 182(8):4608-4615. 10.4049/jimmunol.0713269, 2770841, 19342635.
11. Parker MJ, Xue S, Alexander JJ, Wasserfall CH, Campbell-Thompson ML, Battaglia M, Gregori S, Mathews CE, Song S, Troutt M, et al. Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice. Diabetes 2009, 58(10):2277-2284. 10.2337/db09-0557, 2750219, 19628781.
12. Simon G, Parker M, Ramiya V, Wasserfall C, Huang Y, Bresson D, Schwartz RF, Campbell-Thompson M, Tenace L, Brusko T, et al. Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation. Diabetes 2008, 57(2):405-414.
13. Lopez M, Clarkson MR, Albin M, Sayegh MH, Najafian N. A novel mechanism of action for anti-thymocyte globulin: induction of CD4+CD25+Foxp3+ regulatory T cells. J Am Soc Nephrol 2006, 17(10):2844-2853. 10.1681/ASN.2006050422, 16914538.
14. Feng X, Kajigaya S, Solomou EE, Keyvanfar K, Xu X, Raghavachari N, Munson PJ, Herndon TM, Chen J, Young NS. Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro. Blood 2008, 111(7):3675-3683. 10.1182/blood-2008-01-130146, 2275026, 18250226.
15. Kroemer A, Xiao X, Vu MD, Gao W, Minamimura K, Chen M, Maki T, Li XC. OX40 controls functionally different T cell subsets and their resistance to depletion therapy. J Immunol 2007, 179(8):5584-5591.
16. Ogawa N, Minamimura K, Kodaka T, Maki T. Short administration of polyclonal anti-T cell antibody (ALS) in NOD mice with extensive insulitis prevents subsequent development of autoimmune diabetes. J Autoimmun 2006, 26(4):225-231. 10.1016/j.jaut.2006.03.001, 16713179.
17. Minamimura K, Gao W, Maki T. CD4+ regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J Immunol 2006, 176(7):4125-4132.
18. Boyman O, Letourneau S, Krieg C, Sprent J. Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol 2009, 39(8):2088-2094. 10.1002/eji.200939444, 19637200.
19. Muller TF, Grebe SO, Neumann MC, Heymanns J, Radsak K, Sprenger H, Lange H. Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies. Transplantation 1997, 64(10):1432-1437. 10.1097/00007890-199711270-00010, 9392307.
20. Surh CD, Sprent J. Homeostasis of naive and memory T cells. Immunity 2008, 29(6):848-862. 10.1016/j.immuni.2008.11.002, 19100699.
21. Takada K, Jameson SC. Naive T cell homeostasis: from awareness of space to a sense of place. Nat Rev Immunol 2009, 9(12):823-832. 10.1038/nri2657, 19935802.
22. Michallet MC, Preville X, Flacher M, Fournel S, Genestier L, Revillard JP. Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins. Transplantation 2003, 75(5):657-662. 10.1097/01.TP.0000053198.99206.E6, 12640305.
23. Perruche S, Zhang P, Liu Y, Saas P, Bluestone JA, Chen W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-beta from phagocytes digesting apoptotic T cells. Nat Med 2008, 14(5):528-535. 10.1038/nm1749, 18438416.
24. Matsuoka K, Kim HT, McDonough S, Bascug G, Warshauer B, Koreth J, Cutler C, Ho VT, Alyea EP, Antin JH, et al. Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation. J Clin Invest 2010, 120(5):1479-1493. 10.1172/JCI41072, 2860902, 20389017.
25. Pandiyan P, Zheng L, Ishihara S, Reed J, Lenardo MJ. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells. Nat Immunol 2007, 8(12):1353-1362. 10.1038/ni1536, 17982458.
26. Lowsky R, Takahashi T, Liu YP, Dejbakhsh-Jones S, Grumet FC, Shizuru JA, Laport GG, Stockerl-Goldstein KE, Johnston LJ, Hoppe RT, et al. Protective conditioning for acute graft-versus-host disease. N Engl J Med 2005, 353(13):1321-1331. 10.1056/NEJMoa050642, 16192477.
27. Darrasse-Jeze G, Bergot AS, Durgeau A, Billiard F, Salomon BL, Cohen JL, Bellier B, Podsypanina K, Klatzmann D. Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice. J Clin Invest 2009, 119(9):2648-2662. 2735938, 19652360.
28. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, Serra P, Yang Y, Medarova Z, Moore A, Santamaria P. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 2010, 32(4):568-580. 10.1016/j.immuni.2010.03.015, 20381385.
29. Albert MH, Liu Y, Anasetti C, Yu XZ. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation. Eur J Immunol 2005, 35(9):2598-2607. 10.1002/eji.200526077, 16078276.
30. Zang W, Lin M, Kalache S, Zhang N, Kruger B, Waaga-Gasser AM, Grimm M, Hancock W, Heeger P, Schroppel B, et al. Inhibition of the alloimmune response through the generation of regulatory T cells by a MHC class II-derived peptide. J Immunol 2008, 181(11):7499-7506.
31. DiPaolo RJ, Brinster C, Davidson TS, Andersson J, Glass D, Shevach EM. Autoantigen-specific TGFbeta-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J Immunol 2007, 179(7):4685-4693.
32. Lu Y, Suzuki J, Guillioli M, Umland O, Chen Z. Induction of self-antigen-specific Foxp3+ regulatory T cells in the periphery by lymphodepletion treatment with anti-mouse thymocyte globulin in mice. Immunology 2011, 134(1):50-59. 10.1111/j.1365-2567.2011.03466.x, 3173694, 21711461.